- Weekly Intermittent Treatment: Caution
Dr. Anthony Fauci of the U.S. National Institute of Allergy and Infectious Diseases spoke in Durban about possible strategies to reduce the total amount of antiretroviral drugs needed; he mentioned that five patients are now being treated every other week in a small trial. It is important to understand that these patients had their viral load very well controlled before starting this trial, so that their virus remained essentially undetectable during the week off the drugs; therefore, there was little or no virus present to develop resistance. This strategy would be much more risky for others.
- Selenium: Important New Review of Health Findings
A major literature review offers a credible overview of what is currently known and not known about selenium in human health, and the possibilities of supplementation for some patients.
- Access to Treatment Worldwide: From Talk to Action at Durban
More progress was made at this conference than ever before toward actually getting antiretrovirals and other high-priced medicines to poor countries. For example, a worldwide pricing study by Medecins Sans Frontières (Doctors Without Borders) found some modern antiretroviral combinations could be delivered as generics for about $200 per year per patient, assuming production in large quantities -- and made recommendations for action now by national governments, and by public and private international agencies.
- Selenium: African Studies Reported at Durban
Two presentations at Durban looked at selenium levels and HIV disease in Africa.
- "HIV" Controversy: Nelson Mandela's Call to End Dispute
ISSN # 1052-4207
Copyright 2000 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.